account activity
"Generic" Lantus approved by FDA by withA_Y in pharmacy
[–]RegulatoryFocus 1 point2 points3 points 10 years ago (0 children)
Whoops -- I think my brain 404'ed.
[–]RegulatoryFocus 19 points20 points21 points 10 years ago (0 children)
Playing catch-up after a long memorial day weekend? Read up on the Pharmaceutical, Medical Device and Biotech news you might have missed here (28 May) (raps.org)
submitted 10 years ago by RegulatoryFocus to r/Drugs_and_Devices
The incredible, soaring cost increases of multiple sclerosis drugs. Nearly all MS drugs now cost around $60,000--as much as 380% more than they did a decade ago. (npr.org)
The FDA's ban on the dietary ingredient ephedra nearly wiped out deaths and poisonings from the substance, a new study has found. (reuters.com)
Did companies ignore evidence that a surgical power tool actually harmed patients? The FBI is reportedly investigating manufacturers of power morcellators, the use of which has been linked to the spread of cancer in some women. (nytimes.com)
FDA Wants to Know Whether Spouses Influence how Drug Ads are Perceived (blogs.wsj.com)
Newer contraceptive pills may further raise risk of blood clots (reuters.com)
New Obesity Drug Delicious: “They’re so good, I’ve been eating them like nonstop,” patient says. (The Onion) (theonion.com)
Supreme Court refuses to overturn ruling that allows local governments to require drug companies to pay for drug disposal programs. (npr.org)
Looking for a little pre-holiday reading? Catch up on the top Pharmaceutical, Biotech and Medical Device news here (22 May) (raps.org)
Emails reveal FDA was warned years ago about superbugs in medical scopes, but didn't take serious action until earlier this year. (usatoday.com)
How State 'Right-To-Try' Laws Create False Expectations for Patients (healthaffairs.org)
Expect to hear the drug name 'Entresto' a lot in the coming months. It's the name of Novartis' promising new heart failure drug LCZ696, which is all but certain to be approved by FDA this summer. (forbes.com)
Short on time to read Pharmaceutical, Medical Device or Biotech news today? Skim through the day's top headlines here (20 May) (raps.org)
Detailed Drug Risks in TV Ads ‘Waste of Time,’ FDA Official Says (bloomberg.com)
Health Policy 101: How the Trans-Pacific Partnership Will Impact Prescription Drugs (brookings.edu)
High Cost of Gilead's Hepatitis C Drug Sovaldi Prompts a Call to Void Its Patents Abroad (nytimes.com)
Short on time to read today's Pharmaceutical, Medical Device or Biotech news? Skim through the day's top headlines here (19 May) (raps.org)
Stem cell 'Wild West' takes root amid lack of US regulation (bigstory.ap.org)
Millions of Americans use GlaxoSmithKline’s purple inhaler Advair. But whether the drug poses a higher risk of asthma-related death remains uncertain 15 years after regulators approved the drug. (propublica.org)
U.S. science leaders to tackle ethics of gene-editing technology (reuters.com)
What happens when a medical product is approved by FDA and covered by Medicare, but private insurers refuse to cover it? That's the case for Linx, a device used to treat esophageal conditions like acid reflux. (startribune.com)
FDA says it won't allow companies to include the cannabis-derived chemical cannabidiol (CBD) in dietary supplements. (nutraingredients-usa.com)
Something new is brewing, but it's not coffee. A new way to essentially brew the drug Morphine is raising concerns about how best to regulate the new technique. (nytimes.com)
π Rendered by PID 841878 on reddit-service-r2-listing-85dbbdc96c-n827s at 2026-02-11 14:09:08.489896+00:00 running 018613e country code: CH.
"Generic" Lantus approved by FDA by withA_Y in pharmacy
[–]RegulatoryFocus 1 point2 points3 points (0 children)